STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
AGIO AGIOS PHARMACEUTICALS StockScouter® Report
2
StockScouter® Score
AGIOS PHARMACEUTICALS, a small cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Short-term relative price momentum exhibits meaningful strength. Postive
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- One or more analysts has modestly decreased quarterly earnings estimates for AGIO. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
D
D
F
D